Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Carlone, US

Anthony R. Carlone, Bristol, RI US

Patent application numberDescriptionPublished
20080300638BREAK-OFF SCREW EXTENSIONS - The present invention provides minimally invasive devices and methods for delivering a spinal connector to one or more spinal anchor sites in a patient's spinal column. In one embodiment, a spinal implant and access device is provided that includes a U-shaped receiver member, a bone-engaging member, and an extension member. The U-shaped receiver member can have a recess formed therein that is adapted to seat a spinal connector. The bone-engaging member can extend distally from the receiver member and it can be adapted to engage bone to thereby mate the receiver member to bone. The extension member can extend proximally from the receiver member and it can include a frangible portion formed thereon that is adapted to break when a predetermined force is applied thereto thereby allowing at least a portion of the extension member to be separated from the receiver member.12-04-2008
20090018400SURGICAL RETRACTOR SYSTEMS AND ILLUMINATED CANNULAE - This invention includes surgical retractors that comprise an expandable frame that includes at least two base components, a connector, and at least two retractor blades attached to the expandable frame. Also included are surgical retractors that comprise a housing component that includes a cylindrical portion and a contiguous blade portion, assemblies comprising a surgical retractor assembled to at least one obtruator, illuminated surgical cannulas, and methods of using the same during a surgical procedure.01-15-2009

Patent applications by Anthony R. Carlone, Bristol, RI US

Darrick Carlone, Morristown, NJ US

Patent application numberDescriptionPublished
20110076309Antiperspirant/Deodorant Composition - A composition in which the volatile silicone is partially or fully replaced by a plant oil. The plant oil containing composition is parity or better than the volatile silicone containing material but at lower cost. One example comprises a mixing product of at least one material chosen from antiperspirant actives and deodorant actives; greater than 10 weight % of a plant oil: and less than 40 weight % of a volatile silicone oil. Another examples comprises a mixing product of greater than 10 weight % of a plant oil; a gellant for the composition; and less than 40 weight % of a volatile silicone oil, wherein the composition does not contain an antiperspirant active or deodorant active.03-31-2011
20110076310Antiperspirant/Deodorant Composition - A composition that is gelled with a high level of fatty acid. A composition comprising at least one active chosen from an antiperspirant active and a deodorant active: a fatty acid in an amount of greater than 7 weight %; and a plant oil in an amount of at least 12 weight %. A composition comprising greater than 7 weight % of a fatty acid: and at least 12 weight % of a plant oil, wherein the composition does not contain an antiperspirant active or a deodorant active.03-31-2011

George M. Carlone, Stone Mountain, GA US

Patent application numberDescriptionPublished
20080279880PEPTIDE VACCINES AGAINST GROUP A STREPTOCOCCI - This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A 11-13-2008
20080305123Functional Epitopes of Streptococcus Pneumoniae PsaA Antigen and Uses Thereof - Provided is a P4 peptide, which contains functional epitopes of the PsaA protein of 12-11-2008
20090136548MULTIPLE ANTIGENIC PEPTIDES IMMUNOGENIC AGAINST STREPTOCOCCUS PNEUMONIA - The invention provides a nucleic acid encoding the 37-kDa pneumococcal surface adhesion A protein (PsaA) from 05-28-2009
20100099138MULTIPLE-VALENT OPSONOPHAGOCYTIC ASSAY SELECTION PANEL ARRAYS AND USES THEREFOR - This application discloses a multivalent opsonophagocytosis assay that does not rely on counting of bacterial colonies to determine bacteria viability following opsonophagocytosis. Instead, the method uses a metabolic colorimetric indicator to determine if viable bacteria are present. Also disclosed are arrays that can be used to determine the viability of bacteria following opsonophagocytosis.04-22-2010
20100260802RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE - The present invention relates to recombinant lipidated PsaA proteins and recombinant constructs from which such lipidated PsaA proteins may be expressed. The invention relates further to lipidated PsaA proteins in which lipidation is effected by the use of a heterologous leader sequence derived from the ospA gene of 10-14-2010
20110110969PEPTIDE VACCINES AGAINST GROUP A STREPTOCOCCI - This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A 05-12-2011
20110195075USE OF A PNEUMOCOCCAL P4 PEPTIDE FOR ENHANCING OPSONOPHAGOCYTOSIS IN RESPONSE TO A PATHOGEN - Methods for enhancing opsonophagocytosis of a pathogen of interest are disclosed. The disclosed methods include administering to a subject an isolated P4 peptide, which including the amino acid sequence set forth as SEQ ID NO: 1 and optionally an isolated opsonic antibody or a fragment thereof that specifically binds to an antigen present of the surface of the pathogen of interest. In some examples isolated complement protein or a fragment thereof (for example, a C3a, C3b, iC3b, C3d, C4b, or C5a fragment of a complement protein) is also administering. Compositions contain isolated P4 peptide and one or more isolated opsonic antibodies or a fragment thereof that specifically binds to an antigen present of the surface of a pathogen of interest are also disclosed. In some examples, the compositions also isolated complement protein or fragment thereof, such as one or more of C3a, C3b, iC3b, C3d, C4b, or C5a.08-11-2011

Patent applications by George M. Carlone, Stone Mountain, GA US

Heidi Carlone, Hooksett, NH US

Patent application numberDescriptionPublished
20110262704FLAME RESISTANT COMPOSITE FABRICS - A flame resistant composite fabric includes a first flame resistant fabric layer, a second flame resistant fabric layer, and a barrier layer that bonds the first flame resistant fabric layer to the second flame resistant fabric layer. The barrier layer is capable of withstanding temperature of 500° F. for at least 5 minutes without substantial change in the integrity of the flame resistant composite fabric.10-27-2011